BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Replimune Inc.
Hôpital NOVO
Massive Bio, Inc.
St. Jude Children's Research Hospital
Travera Inc
Fudan University
Marengo Therapeutics, Inc.
Vejle Hospital
Stanford University
Melanoma and Skin Cancer Trials Limited
Iovance Biotherapeutics, Inc.
Simcha IL-18, Inc.